As core minimally invasive puncture medical devices used in hematology and oncology departments, bone marrow biopsy needles rely heavily on material performance to guarantee operational safety, puncture accuracy and service life, which constitutes the fundamental research and production priority for medical device manufacturers. Currently, mainstream 8G-26G full-range bone marrow biopsy needles in the industry adopt medical-grade stainless steel as the core substrate paired with auxiliary materials for precision forming. Such products comply with production standards for Class III puncture devices domestically and international safety specifications for medical consumables, serving as core guarantees for safe clinical tissue sampling.

Medical-grade stainless steel stands as the preferred material for bone marrow biopsy needles, distinctly different from ordinary industrial stainless steel. It features outstanding biocompatibility, corrosion resistance and structural stability suitable for human minimally invasive puncture procedures. Bone marrow puncture is an invasive diagnosis operation where instruments directly contact human bone tissue, bone marrow and body fluids. Conventional steel is prone to oxidation, rusting and precipitation of metal ions, likely triggering local inflammation, allergies or cross-infection in patients. In contrast, the special medical stainless steel selected by manufacturers undergoes refined ratio purification free of harmful heavy metals. After electropolishing, the surface becomes smooth without burrs or pores, effectively preventing tissue adhesion and cell residue while significantly lowering postoperative infection risks. In addition, the material strikes a balance between hardness and toughness. It satisfies the rigidity requirement of 8G thick needles for penetrating cortical bone, and maintains appropriate flexibility for 26G thin needles used in minimally invasive puncture to avoid bending or breakage during clinical operations.

Material requirements vary for different gauges covering the 8G-26G range. Large-size biopsy needles of 8G, 11G and 13G are applied to harvest massive bone marrow tissue from adult patients. With thicker shafts, they demand high compressive strength from stainless steel to resist deformation during puncture and retrieve intact bone marrow trabecular specimens. Medium gauges from 14G to 18G represent general-purpose models for standard adult biopsy and older children's diagnosis, requiring balanced comprehensive material properties. Fine gauges ranging from 20G to 26G target minimally invasive treatment for infants, frail patients and precise sampling scenarios. Manufacturers adopt precise cold rolling technology for stainless steel to retain sufficient structural strength while fabricating slender needle shafts and eliminate bending risks during puncture.

In line with industrial production specifications, stainless steel bone marrow biopsy needles must pass multiple quality inspection procedures. Manufacturers strictly implement finishing processes including polishing, rust removal, passivation and electropolishing to eliminate tiny surface burrs and stress concentration points. Laser marking is applied to imprint centimeter depth scales with high precision and wear resistance. Moreover, materials need to pass authoritative tests including biocompatibility, sterility and cytotoxicity verification to ensure disposable products are pyrogen-free and non-sensitizing. For reusable products, material performance remains stable after repeated high-temperature sterilization and disinfection without degradation.

Against the backdrop of upgrading medical device industry standards, manufacturers continuously optimize processing techniques for stainless steel combined with necking, swaging and precision grinding to further improve needle accuracy and surface finish. Compared with biopsy needles made of traditional materials, modern stainless steel alternatives deliver higher specimen integrity, less trauma to patients and broader clinical adaptability. They fully meet diagnostic demands for hematological disorders, screening of metastatic bone tumors and detection of myelofibrosis, establishing a benchmark material solution for standardized industrial production.